Knockdown of MPC1 in prostate cancer cells increased glycolysis and cell invasion, and more importantly abrogated the effect on glycolysis, cell growth and invasion upon COUP-TFII knockdown. The gene discussed is NR2F2; the disease is prostate carcinoma.